Oxford Ledge
Search
Market prices for BRKR are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.
Bruker Corporation (NASDAQ: BRKR) is a medical device company. Figures from SEC EDGAR; updated 2026-10-20 13:43 UTC.
The company develops, manufactures, and distributes scientific instruments and analytical solutions that enable customers to examine materials at microscopic, molecular, and cellular levels. Its products detect, measure, and visualize structural characteristics of chemical, biological, and industrial samples for use in life science research, biopharmaceuticals, microbiology, diagnostics, and nanotechnology. The company operates four business segments that use technology platforms including magnetic resonance, mass spectrometry, chromatography, X-ray, microscopy, and spectroscopy.
Summarized from Bruker Corporation’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗
| Valuation | |
| EPS (TTM) | $-0.70 |
| Debt/equity | 0.75 |
Bruker Corp. (BRKR) reported 1 operating metric for Q2 2026 in its SEC earnings exhibit filed 2026-08-04.
Most recent reported period: Q2 2026, filed 2026-08-04.
See how BRKR compares across the industry →
Oxford Ledge Signal — extracted from the issuer’s own SEC earnings exhibit and normalized by Oxford Ledge; as reported by the issuer per regulatory convention, not re-audited by us. Source: SEC EDGAR ↗
| Revenue growth | -0.8% organic · non-GAAP, no reconciliation |
Every figure in this table is a CHANGE the issuer reported for the period, not a level. Growth rates and levels never share a column or a table -- a change read as a level is a different number entirely.
Oxford Ledge Signal — extracted from the issuer’s own SEC earnings exhibit and normalized by Oxford Ledge; as reported by the issuer per regulatory convention, not re-audited by us. Source: SEC EDGAR ↗
The company develops, manufactures, and distributes scientific instruments and analytical solutions that enable customers to examine materials at microscopic, molecular, and cellular levels.
Bruker Corporation's most recent SEC filing on record is a 8-K filed 2026-08-14. All filings link to their SEC EDGAR originals above.
SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 13:43 UTC. This page is also available as JSON at /api/data?ticker=BRKR and is emitted with FAQPage structured data for machine reading.
Charts, 10-year financials, peer comparison, screening and portfolio tracking for BRKR and 5,000+ tickers.
Create a free account — keep BRKRGET /api/data?ticker=BRKR
This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt